alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Term ID

CHEBI:61711

Synonyms

(Gal)1 (GlcNAc)1 (LFuc)1 (Neu5Ac)1
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D-glucosamine
alpha-Neu5Ac-(2->3)-beta-D-Gal (1->4)-[alpha-L-Fuc-(1->3)]-D-GlcNAc
NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAc
sialyl Lewis X
sialyl Lewis x antigen
sialyl Lewis x mimetic
sialyl-Lewis x antigen

Definition

A branched amino tetrasaccharide consisting of a sialyl residue, linked (2→3) to a galactosyl residue that in turn is linked (1→4) to a glucosaminyl residue, which is also carrying a fucosyl residue at the 3-position.

References

glygen:G90387AM
glytoucan:G90387AM
kegg.glycan:G00242
pubmed:10211987
pubmed:10789451
pubmed:10852628
pubmed:10969978
pubmed:11408160
pubmed:11872958
pubmed:12015815
pubmed:14601054
pubmed:16133831
pubmed:7691279
pubmed:8632441
pubmed:8818228
pubmed:8879537
pubmed:9357520
pubmed:9639536
reaxys:7162134

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype affecting alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Human Disease Model